scholarly journals NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study

2021 ◽  
Author(s):  
Cândida Fonseca ◽  
Paulo Bettencourt ◽  
Dulce Brito ◽  
Helena Febra ◽  
Álvaro Pereira ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Budget Impact ◽  
Failure Diagnosis ◽  
Impact Study ◽  
Heart Failure Diagnosis ◽  
Care Costs

Association of depression and anxiety with adherence in primary care patients with heart failure—cross-sectional results of the observational RECODE-HF cohort study

2020 ◽  
Vol 37 (5) ◽  
pp. 695-702 ◽  
Author(s):  
Marion Eisele ◽  
Malte Harder ◽  
Anja Rakebrandt ◽  
Sigrid Boczor ◽  
Gabriella Marx ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Cohort Study ◽  
Psychological Distress ◽  
Medication Adherence ◽  
Failure Diagnosis ◽  
Cross Sectional ◽  
Factors Associated ◽  
Patients With Heart Failure ◽  
Heart Failure Diagnosis

Abstract Background Psychological distress has a negative impact on the prognosis and quality of life for patients with heart failure. We investigated the association between psychological distress and the patients’ adherence to medical treatment (medication adherence) and self-care advice (lifestyle adherence) in heart failure. We further examined whether there are different factors associated with low medication compared to low lifestyle adherence. Method This secondary analysis of the RECODE-HF cohort study analyzed baseline data of 3099 primary care heart failure patients aged 74 ± 10 years, 44.5 % female. Using multivariable regression, factors relating to medication and lifestyle adherence were investigated in order to estimate the extent to which these factors confound the association between psychological distress and adherence. Results Psychological distress was significantly associated with poorer medication adherence but not with lifestyle adherence after controlling for confounders. We identified different factors associated with medication compared to lifestyle adherence. A higher body mass index, a less developed social network, living alone, fewer chronic co-morbidities and unawareness of the heart failure diagnosis were only related to lower lifestyle adherence. Higher education was associated with poorer medication adherence. Male sex, younger age, lower self-efficacy and less familiar relation with the general practitioner were common factors associated with both lower medication and lifestyle adherence. Conclusion Promising factors for increasing medication adherence (reduction of psychological distress) and lifestyle adherence (explaining the patient his/her heart failure diagnosis more than once and increase in the patients’ self-efficacy), which were found in this cross-sectional study, must be further investigated in longitudinal studies.

Lung Ultrasound for Heart Failure Diagnosis in Primary Care

2020 ◽  
Vol 26 (10) ◽  
pp. 824-831 ◽  
Author(s):  
LAURA CONANGLA ◽  
MAR DOMINGO ◽  
JOSEP LUPÓN ◽  
ASUNCIÓN WILKE ◽  
GLADYS JUNCÀ ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Lung Ultrasound ◽  
Failure Diagnosis ◽  
Heart Failure Diagnosis

scholarly journals Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study

2017 ◽  
Vol 23 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Jose María Verdú-Rotellar ◽  
Eva Frigola-Capell ◽  
Rosa Alvarez-Pérez ◽  
Daniela da Silva ◽  
Cristina Enjuanes ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Cross Sectional Study ◽  
Failure Diagnosis ◽  
Sectional Study ◽  
Cross Sectional ◽  
Heart Failure Diagnosis

scholarly journals Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England

2019 ◽  
Vol 48 (3) ◽  
pp. 347-354 ◽  
Author(s):  
Alex Bottle ◽  
Dani Kim ◽  
Benedict Hayhoe ◽  
Azeem Majeed ◽  
Paul Aylin ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Observational Study ◽  
Population Based ◽  
Failure Diagnosis ◽  
Primary Care Population ◽  
Co Morbidity ◽  
Heart Failure Diagnosis

scholarly journals Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
William Hinton ◽  
Michael D. Feher ◽  
Neil Munro ◽  
Mark Joy ◽  
Simon de Lusignan
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Primary Care ◽  
Renal Function ◽  
Failure Diagnosis ◽  
Prescribing Patterns ◽  
Obese People ◽  
Glucose Lowering ◽  
Heart Failure Diagnosis

Abstract Background Sodium-glucose co-transporter-2 inhibitors (SGLT-2is) are licenced for initiation for glucose lowering in people with type 2 diabetes (T2DM) with an estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73m2). However, recent trial data have shown that these medications have renal and cardio-protective effects, even for impaired kidney function. The extent to which trial evidence and updated guidelines have influenced real-world prescribing of SGLT-2is is not known, particularly with co-administration of diuretics. Methods We performed a cross-sectional analysis of people with T2DM registered with practices in the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) database on the 31st July 2019. We calculated the percentage of people prescribed SGLT-2is according to eGFR categories (< 45, 45–59, and ≥ 60 mL/min/1.73m2), with a heart failure diagnosis and stratified by body mass index categories (underweight, normal weight, overweight, obese), and with concomitant prescription of a diuretic. Multilevel logistic regression analysis was performed to determine whether heart failure diagnosis and renal function were associated with SGLT-2i prescribing. Results From a population of 242,624 people with T2DM across 419 practices, 11.0% (n = 26,700) had been prescribed SGLT-2is. The majority of people initiated SGLT-2is had an eGFR ≥ 60 mL/min/1.73m2 (93.2%), and 4.3% had a heart failure diagnosis. 9,226 (3.8%) people were prescribed SGLT-2is as an add-on to their diuretic prescription. People in the highest eGFR category (≥ 60 mL/min/1.73m2) were more likely to be prescribed SGLT-2is than those in eGFR lower categories. Overweight (OR 2.05, 95% CI 1.841–2.274) and obese people (OR 3.84, 95% CI 3.472–4.250) were also more likely to be prescribed these medications, whilst use of diuretics (OR 0.74, 95% CI 0.682–0.804) and heart failure (OR 0.81, 95% CI 0.653–0.998) were associated with lower odds of being prescribed SGLT-2is. Conclusions Prescribing patterns of SGLT-2is for glucose lowering in T2DM in primary care generally concur with licenced indications according to recommended renal thresholds. A small percentage of people with heart failure were prescribed SGLT-2is for T2DM. An updated analysis is merited should UK National Institute for Health Care and Excellence prescribing guidelines for T2DM be revised to incorporate new data on the benefits for those with reduced renal function or with heart failure.

Sign in / Sign up

Export Citation Format

Share Document